[
    "{\"step_by_step_thinking\": \"Based on the provided documents, there is no consistent evidence to suggest that angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) increase the likelihood of severe COVID-19. Multiple studies and meta-analyses have shown that the use of ACE inhibitors and ARBs is not associated with increased mortality, severity, or risk of infection with SARS-CoV-2. Some studies even suggest a potential protective effect of ACE inhibitors and ARBs. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]